[go: up one dir, main page]

EE04296B1 - Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini - Google Patents

Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini

Info

Publication number
EE04296B1
EE04296B1 EEP200100014A EEP200100014A EE04296B1 EE 04296 B1 EE04296 B1 EE 04296B1 EE P200100014 A EEP200100014 A EE P200100014A EE P200100014 A EEP200100014 A EE P200100014A EE 04296 B1 EE04296 B1 EE 04296B1
Authority
EE
Estonia
Prior art keywords
sertraline
agent containing
antidepressant agent
containing pramipexole
pramipexole
Prior art date
Application number
EEP200100014A
Other languages
English (en)
Estonian (et)
Inventor
Maj Jerzy
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of EE200100014A publication Critical patent/EE200100014A/xx
Publication of EE04296B1 publication Critical patent/EE04296B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200100014A 1998-07-07 1999-07-02 Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini EE04296B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830201A DE19830201A1 (de) 1998-07-07 1998-07-07 Mittel mit antidepressiver Wirkung
PCT/EP1999/004595 WO2000002542A2 (de) 1998-07-07 1999-07-02 Mittel mit antidepressiver wirkung, enthaltend pramipexol und ein weiteres antidepressivum

Publications (2)

Publication Number Publication Date
EE200100014A EE200100014A (et) 2002-06-17
EE04296B1 true EE04296B1 (et) 2004-06-15

Family

ID=7873155

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100014A EE04296B1 (et) 1998-07-07 1999-07-02 Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini

Country Status (32)

Country Link
US (1) US6255329B1 (xx)
EP (1) EP1093369B1 (xx)
JP (1) JP2002520273A (xx)
KR (1) KR100557692B1 (xx)
CN (1) CN1230168C (xx)
AR (1) AR019896A1 (xx)
AT (1) ATE228365T1 (xx)
AU (1) AU762128B2 (xx)
BG (1) BG64972B1 (xx)
BR (1) BR9911768A (xx)
CA (1) CA2336833C (xx)
CZ (1) CZ294087B6 (xx)
DE (2) DE19830201A1 (xx)
DK (1) DK1093369T3 (xx)
EA (1) EA003142B1 (xx)
EE (1) EE04296B1 (xx)
ES (1) ES2183583T3 (xx)
HU (1) HUP0103922A3 (xx)
ID (1) ID27776A (xx)
IL (1) IL140603A0 (xx)
MY (1) MY117969A (xx)
NO (1) NO20010064L (xx)
NZ (1) NZ509729A (xx)
PL (1) PL195043B1 (xx)
PT (1) PT1093369E (xx)
RS (1) RS49795B (xx)
SK (1) SK284923B6 (xx)
TR (1) TR200100146T2 (xx)
TW (1) TW592698B (xx)
WO (1) WO2000002542A2 (xx)
YU (1) YU401A (xx)
ZA (1) ZA200100090B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006162A1 (de) * 1998-07-27 2000-02-10 Boehringer Ingelheim Pharma Kg Mittel mit antidepressiver wirkung, mit pramipexol und einem weiteren antidepressivum
WO2002069974A1 (en) * 2001-03-05 2002-09-12 Andrew Holman Administration of sleep restorative agents
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
ATE480235T1 (de) * 2001-12-11 2010-09-15 Univ Virginia Verwendung von pramipexol zur behandlung von amyotrophischer lateralsklerose
US20060281797A1 (en) * 2001-12-11 2006-12-14 University Of Virginia Patent Foundation Neurorestoration with R(+) Pramipexole
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
CA2554616A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
EP1917014B1 (en) * 2005-08-15 2009-10-07 University Of Virginia Patent Foundation Neurorestoration with r(+) pramipexole
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
CN102160865A (zh) 2006-05-16 2011-08-24 诺普神经科学股份有限公司 R(+)和s(-)普拉克索的组合物以及使用该组合物的方法
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
JP2010521496A (ja) 2007-03-14 2010-06-24 ノップ ニューロサイエンシーズ、インク. キラル精製置換ベンゾチアゾールジアミンの合成
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
EP2334185A4 (en) * 2008-08-19 2011-09-21 Knopp Neurosciences Inc COMPOSITIONS AND METHODS FOR USE OF (R) -PRAMIPEXOL
WO2010028207A2 (en) 2008-09-05 2010-03-11 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (adhd)
AU2010242971A1 (en) * 2009-04-30 2011-11-24 Supernus Pharmaceuticals, Inc. Method of treatment of depression
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
MX356727B (es) 2012-02-08 2018-06-12 Supernus Pharmaceuticals Inc Formulaciones de liberacion modificada de viloxacina.
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
SMT202100119T1 (it) 2013-07-12 2021-05-07 Knopp Biosciences Llc Trattamento dei livelli elevati di eosinofili e/o basofili
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
EP3033081B1 (en) 2013-08-13 2021-05-12 Knopp Biosciences LLC Compositions and methods for treating chronic urticaria
ES2813674T3 (es) 2013-08-13 2021-03-24 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b
IL312486B2 (en) * 2017-04-10 2025-05-01 Chase Therapeutics Corp NK1 antagonist combination and method for treating synucleinopathies
BR112019028034A2 (pt) * 2017-06-30 2020-07-07 Chase Therapeutics Corporation composições de antagonista de nk-1 e métodos para uso no tratamento da depressão
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
DE3572485D1 (en) * 1984-12-22 1989-09-28 Thomae Gmbh Dr K Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
NZ325914A (en) * 1996-03-29 1999-09-29 Pfizer Benzyl(idene)-lactam derivatives and salts thereof, their preparation and their use as selective (ant)agonists of 5-ht1a and/or 5-ht1d receptors and thus are effective as psychotherapeutic agents
ATE282417T1 (de) * 1996-12-02 2004-12-15 Merck Sharp & Dohme Die verwendung von nk-1 rezeptor antagonisten für die behandlung von bewegungsstörungen
EP1047436B1 (en) * 1998-01-13 2009-10-21 Synchroneuron, LLC N-acetylhomotaurinates for use in treating hyperkinesias

Also Published As

Publication number Publication date
DK1093369T3 (da) 2002-12-16
AU5030399A (en) 2000-02-01
CZ200177A3 (en) 2001-06-13
EP1093369A2 (de) 2001-04-25
YU401A (sh) 2003-10-31
CN1230168C (zh) 2005-12-07
IL140603A0 (en) 2002-02-10
DE19830201A1 (de) 2000-01-13
KR20010079491A (ko) 2001-08-22
AR019896A1 (es) 2002-03-20
HUP0103922A3 (en) 2002-08-28
HK1037976A1 (en) 2002-03-01
AU762128B2 (en) 2003-06-19
WO2000002542A2 (de) 2000-01-20
BG105112A (bg) 2001-10-31
JP2002520273A (ja) 2002-07-09
DE59903556D1 (de) 2003-01-09
NO20010064D0 (no) 2001-01-05
TW592698B (en) 2004-06-21
ZA200100090B (en) 2002-04-04
CZ294087B6 (cs) 2004-10-13
BR9911768A (pt) 2001-04-03
MY117969A (en) 2004-08-30
ID27776A (id) 2001-04-26
KR100557692B1 (ko) 2006-03-07
US6255329B1 (en) 2001-07-03
ES2183583T3 (es) 2003-03-16
SK112001A3 (en) 2001-10-08
EE200100014A (et) 2002-06-17
NZ509729A (en) 2003-06-30
CA2336833C (en) 2008-09-23
RS49795B (sr) 2008-06-05
CA2336833A1 (en) 2000-01-20
EA200100084A1 (ru) 2001-08-27
NO20010064L (no) 2001-03-02
PL345842A1 (en) 2002-01-14
HUP0103922A2 (hu) 2002-03-28
SK284923B6 (sk) 2006-02-02
WO2000002542A3 (de) 2000-06-22
PT1093369E (pt) 2003-03-31
TR200100146T2 (tr) 2001-07-23
EP1093369B1 (de) 2002-11-27
PL195043B1 (pl) 2007-08-31
EA003142B1 (ru) 2003-02-27
CN1308533A (zh) 2001-08-15
ATE228365T1 (de) 2002-12-15
BG64972B1 (bg) 2006-11-30

Similar Documents

Publication Publication Date Title
EE04296B1 (et) Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini
ID28787A (id) 2-fenilbenzimidazol tersubstitusi, pembuatannya dan penggunaannya
EE200000766A (et) Ravimkoostis, mis sisaldab COX-2 inhibiitorit ja iNOS inhibiitorit
ID30393A (id) Senyawa tienopirimidina, pembuatan dan penggunaannya
MA26866A1 (fr) Agents antibacteriens consistant en 3-aminoquinazoline-2,4-diones
NO20005503D0 (no) Ny anvendelse
ID22957A (id) Senyawa dan penggunaannya
DE69929047D1 (de) Haarbehandlungsmittel
DE69919970D1 (de) Axiallüfter
NL1016224A1 (nl) Foto-basevormend middel en foto-zuurvormend middel bevattende foto- etssamenstelling.
DE69822124T2 (de) Axiallüfter
EE04297B1 (et) Budesoniidi ja formoterooli uus kasutamine
ID27922A (id) KOMPOSISI FARMASETIKAL DAN PENGGUNAAN DARI ANDROST-5-ENA-3β, 17β-DIOL
DK1112003T3 (da) Ny sammensætning og anvendelse
DE69921931D1 (de) Axiallüfter
NO20001847L (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
IS5951A (is) 5HT1 mótlyf fyrir meðferð gegn þunglyndi
DZ2547A1 (fr) Formes posologiques de sertraline à libération prolongée.
NO20010654L (no) Ny anvendelse av taxoidderivater
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
PT941081E (pt) Nova utilizacao de creatina
NO20005483L (no) Ny sammensetning
IL162014A0 (en) Shape-recovering material suitable for application of an attachment, and its use
SI1093369T1 (sl) Sredstvo z antidepresivnim učinkom, ki obsega pramipeksol in sertralin
DE59700357D1 (de) Herstellung aromatischer Nitrile

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20090702